Respiratory management specialist Adherium (ASX: ADR) has reported its fourth consecutive quarter of record remote patient monitoring (RPM) revenue with a total $479,000 achieved for the three months to end June. The company continued to scale its RPM business during the period, driving further growth in recurring revenue and delivering quarter-on-quarter commercial momentum. Improving Patient OutcomesAdherium’s Hailie Smartinhaler technology featured in data presented at a global conference of the American Thoracic Society. Adherium recorded a total of $408,000 in customer cash receipts for period, representing a 79% increase on $228,000 achieved in the March quarter. At end June, the company had $1.38 million cash at hand compared to $2.95m in the March quarter.